MetaCap

Oruka Therapeutics (ORKA) News

NASDAQ: ORKAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

95.81-1.76 (-1.80%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ORKA news summary

We found 7 recent headlines mentioning Oruka Therapeutics (ORKA): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, ORKA is down 1.80% at $95.81. The most recent story, "Oruka Expects ORKA-001 52-Week Data In December; Phase 3 Start Planned For 2027", was published by Nasdaq on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Oruka Therapeutics headlines

Stocks mentioned alongside ORKA

Compare ORKA